Data for CDK4/6 and SOS1 programs highlight differentiated therapeutic profiles BTX-9341 nominated as development candidate for CDK4/6 degrader program for[…] Read More
Need help?
Contact usData for CDK4/6 and SOS1 programs highlight differentiated therapeutic profiles BTX-9341 nominated as development candidate for CDK4/6 degrader program for[…] Read More